GGrantIndex
Sort

24,827 grants matching epilepsy

Brain Imaging And Modeling

$745,749
Barry Horwitz · National Institute On Deafness And Other Communication Disorders · ZIA · FY2016 · DC

Meaningful Outcomes and Multi-Site Readiness for Clinical Trials in Juvenile Neuronal Ceroid Lipofuscinosis

$745,729
Erika Augustine · University Of Rochester · U01 · FY2021 · NS

EPIGENETIC THERAPY FOR POST-TRAUMATIC EPILEPSY

$745,304
Texas A & M University System Health Science Center · · FY2022 · Department of the Army

Glutamate receptors and human neurological disease

$745,173
Stephen F. Traynelis · Emory University · R35 · FY2020 · NS

Glutamate receptors and human neurological disease

$745,051
Stephen F. Traynelis · Emory University · R35 · FY2024 · NS

New Tools to Study Neurosteroid Estrogens

$744,809
Catherine S Woolley · Northwestern University · R01 · FY2017 · MH

High Performance Seizure Monitoring and Alert System

$744,779
Deng-Shan Shiau · Optima Neuroscience, Inc. · R44 · FY2011 · NS

Scalable tool and comprehensive maps to interpret structural variation across the neuropsychiatric spectrum

$744,441
Michael E Talkowski · Broad Institute, Inc. · R01 · FY2023 · MH

SUDEP Translational Research Alliance (SUTRA)Informatics & Data Analytics Core (IDAC): SUTRA-2 of 7

$744,331
Guo-Qiang Zhang · Case Western Reserve University · U01 · FY2014 · NS

Novel pediatric anticonvulsants for nerve agents

$744,154
Doodipala Samba Reddy · Texas A&M University Health Science Ctr · U01 · FY2022 · NS

Mechanisms of focal epileptogenesis in mTORopathies

$743,776
Steve C Danzer · Cincinnati Childrens Hosp Med Ctr · R35 · FY2025 · NS

Clinical and Basic Science Studies in Long QT Syndrome Type 3

$742,812
Wojciech Zareba · University Of Rochester · R01 · FY2017 · HL

Seizures and Children's Outcomes after Stroke (SCOUTS)

$742,670
Christine K. Fox · University Of California, San Francisco · R01 · FY2022 · NS

Clinical and Basic Science Studies in Long QT Syndrome Type 3

$742,413
Arthur J. Moss · University Of Rochester · R01 · FY2014 · HL

Development of cGMP Manufacturing Process for CBD

$742,149
Trevor P. Castor · Aphios Corporation · R44 · FY2015 · DA

Development of cGMP Manufacturing Process for CBD

$742,149
Trevor P. Castor · Aphios Corporation · R44 · FY2016 · DA

Cell Identity Determination In Human Brain: Somatic mutation and cell lineage

$741,754
Christopher A Walsh · Boston Children'S Hospital · R01 · FY2020 · NS

Involvement Of Human Viruses Associated With Chronic Neurologic Disease

$741,698
Steven Jacobson · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS

Development of EP2 receptor antagonists for suppression of Alzheimer's neuropathology

$741,585
Thota Ganesh · Emory University · U01 · FY2017 · AG

Development of a galanin-based therapy for the treatment of refractory epilepsy

$741,557
H Steve White · University Of Utah · U01 · FY2010 · NS

Studies of direct and transthalamic pathways in visual cortex

$741,499
W Martin Usrey · University Of California At Davis · R01 · FY2024 · EY

Effects of vascular risk factors on risk for dementia and stroke after late-onset epilepsy (EpilepsyCOG)

$741,409
Hyunmi Choi · Columbia University Health Sciences · R01 · FY2025 · AG

Development of mGlu7 receptor allosteric modulators for neurological and psychiatric disorders

$741,117
Colleen M Niswender · Vanderbilt University · R01 · FY2020 · MH

Genetics of AD Partial Epilepsy with Auditory Features

$741,112
Ruth Ottman · Columbia University Health Sciences · R01 · FY2007 · NS

Genetic targeting of cortical pyramidal neuron subtypes

$741,089
Z Josh Huang · Cold Spring Harbor Laboratory · R01 · FY2017 · MH